[{"address1": "302 East Pettigrew St.", "address2": "Suite A-100", "city": "Durham", "state": "NC", "zip": "27701", "country": "United States", "phone": "919 314 5512", "fax": "480 393 5553", "website": "https://precisionbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Amoroso", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1094351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jefferson J. Smith Ph.D.", "age": 51, "title": "Co-Founder & Chief Research Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 640195, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Alexander Kelly R.Ph.", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cassie  Gorsuch Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naresh  Tanna", "title": "Chief of Staff to CEO & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Scimeca J.D.", "age": 49, "title": "General Counsel & Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 576432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Juli  Blanche", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy  Atwell", "title": "Chief Development & Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Leatherbury M.S.", "title": "Senior VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.85, "open": 5.74, "dayLow": 5.7, "dayHigh": 6.035, "regularMarketPreviousClose": 5.85, "regularMarketOpen": 5.74, "regularMarketDayLow": 5.7, "regularMarketDayHigh": 6.035, "payoutRatio": 0.0, "beta": 1.086, "forwardPE": -0.86725664, "volume": 189252, "regularMarketVolume": 189252, "averageVolume": 143885, "averageVolume10days": 290790, "averageDailyVolume10Day": 290790, "bid": 5.72, "ask": 5.92, "bidSize": 1, "askSize": 1, "marketCap": 141541904, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 8.82, "allTimeHigh": 710.1, "allTimeLow": 3.61, "priceToSalesTrailing12Months": 202.7821, "fiftyDayAverage": 5.9496, "twoHundredDayAverage": 5.184275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 62207696, "profitMargins": 0.0, "floatShares": 12007435, "sharesOutstanding": 24071751, "sharesShort": 485968, "sharesShortPriorMonth": 1136843, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0367, "heldPercentInsiders": 0.10135999, "heldPercentInstitutions": 0.4071, "shortRatio": 2.94, "shortPercentOfFloat": 0.0376, "impliedSharesOutstanding": 13256751, "bookValue": 1.377, "priceToBook": 4.2701526, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -83602000, "trailingEps": -8.96, "forwardEps": -6.78, "lastSplitFactor": "1:30", "lastSplitDate": 1707868800, "enterpriseToRevenue": 89.123, "enterpriseToEbitda": -0.708, "52WeekChange": -0.19421488, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 5.88, "targetHighPrice": 60.0, "targetLowPrice": 19.0, "targetMeanPrice": 32.5, "targetMedianPrice": 25.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 44870000, "totalCashPerShare": 3.385, "ebitda": -87925000, "totalDebt": 29128000, "quickRatio": 2.992, "currentRatio": 3.448, "totalRevenue": 698000, "debtToEquity": 175.111, "revenuePerShare": 0.069, "returnOnAssets": -0.45337, "returnOnEquity": -2.05158, "grossProfits": 698000, "freeCashflow": -37418000, "operatingCashflow": -73276000, "revenueGrowth": -0.977, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1589.7692, "financialCurrency": "USD", "symbol": "DTIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763167803, "regularMarketTime": 1763154001, "exchange": "NCM", "messageBoardId": "finmb_41018856", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1553779800000, "postMarketChangePercent": 3.2312934, "postMarketPrice": 6.07, "postMarketChange": 0.19000006, "regularMarketChange": 0.0300002, "regularMarketDayRange": "5.7 - 6.035", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 143885, "fiftyTwoWeekLowChange": 2.2700002, "fiftyTwoWeekLowChangePercent": 0.6288089, "fiftyTwoWeekRange": "3.61 - 8.82", "fiftyTwoWeekHighChange": -2.9399996, "fiftyTwoWeekHighChangePercent": -0.33333328, "fiftyTwoWeekChangePercent": -19.421488, "earningsTimestamp": 1762176600, "earningsTimestampStart": 1762176600, "earningsTimestampEnd": 1762176600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -8.96, "epsForward": -6.78, "epsCurrentYear": -6.57, "priceEpsCurrentYear": -0.89497715, "fiftyDayAverageChange": -0.069600105, "fiftyDayAverageChangePercent": -0.011698282, "twoHundredDayAverageChange": 0.69572496, "twoHundredDayAverageChangePercent": 0.13419908, "sourceInterval": 15, "shortName": "Precision BioSciences, Inc.", "longName": "Precision BioSciences, Inc.", "regularMarketChangePercent": 0.512824, "regularMarketPrice": 5.88, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Precision BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]